Motley Rice HOME

Reglan Lawyer

Motley Rice is reviewing potential cases involving people who may have experienced adverse side effects following the use of Reglan, a pharmaceutical drug prescribed for the treatment of gastrointestinal ailments.

Reglan (metoclopramide) is a drug used to treat a number of gastrointestinal ailments, including GERD, acid reflux and diabetic gastroparesis, and is used by some obstetricians to treat morning sickness in pregnant women.  Researchers have linked Reglan use to the development of Tardive Dyskinesia, a condition causing involuntary repetitive movement.  This condition is characterized by symptoms similar to Parkinson’s Syndrome that are rarely reversible.

Contact Motley Rice

Contact a Reglan Lawyer

If you or a loved one may have experienced adverse symptoms, contact Reglan lawyer Carmen Scott by email or call +1 800.768.4026. 

Reglan Side Effects

Side effects or diagnoses associated with the use of Reglan may include:

  • Akathasia
  • Cervical dystonia (torticollis)
  • Face Grimacing
  • Facial tics
  • Impaired movement of the fingers
  • Involuntary/ repetitive movements of the extremities
  • Lip smacking, pursing and puckering
  • Neuroleptic malignant syndrome
  • Parkinsons symptoms
  • Rapid eye movements or blinking
  • Restless Leg Syndrome (RLS)
  • Tardive dyskinesia
  • Tongue protrusion

Reglan History and Potential Dangers

On February 26, 2009, the FDA announced that manufacturers of metoclopramide-containing drugs must place a “black box” warning on these drugs’ labels to warn of risks of high-dose or long-term use.  Specifically, the FDA required that the black box warn that Reglan/metoclopramide users could develop Tardive Dyskinesia, even after stopping the drug.  The FDA stated:

“Recently published analyses suggest that metoclopramide is the most common cause of drug-induced movement disorders. Another analysis of study data by the FDA showed that about 20 percent of patients in that study who used metoclopramide took it for longer than three months. The FDA has also become aware of continued spontaneous reports of tardive dyskinesia in patients who used metoclopramide, the majority of whom had taken the drug for more than three months.”

While Reglan/metoclopramide was not recalled or removed from the market, the FDA now requires manufacturers to provide users with a medication guide discussing this risk through a risk evaluation and mitigation strategy.  Click here to read the full FDA news release. 

It is estimated that over two million people in the United States use Reglan or other metoclopramide-containing drugs.  Reglan is available in multiple forms including tablets, oral solution and injection.